KV Pharmaceutical Newswire

KV Pharmaceutical Newswire

Comprehensive Real-Time News Feed for KV Pharmaceutical.

Results 1 - 4 of 4 in KV Pharmaceutical

  1. Study: Common drug used to prevent preterm births provides no benefit but may cause side effectsRead the original story w/Photo

    Mar 15, 2017 | Medical News

    ... of 17-OHPC. In addition, many complaints centered on the drug's price. Before the FDA's approval for KV Pharmaceutical (now Lumara Health) to market the drug, it was often bought at compounding pharmacies, which produced the injectable medication ...

    Comment?

  2. Study finds no benefit, but possible harm, from drug used to prevent preterm birthsRead the original story w/Photo

    Mar 14, 2017 | PhysOrg Weblog

    ... of 17-OHPC. In addition, many complaints centered on the drug's price. Before the FDA's approval for KV Pharmaceutical (now Lumara Health) to market the drug, it was often bought at compounding pharmacies, which produced the injectable medication ...

    Comment?

  3. Study Finds No Benefit, but Possible Harm, From Drug Used to Prevent Preterm BirthsRead the original story

    Mar 14, 2017 | Newswise

    ... of 17-OHPC. In addition, many complaints centered on the drug's price. Before the FDA's approval for KV Pharmaceutical (now Lumara Health) to market the drug, it was often bought at compounding pharmacies, which produced the injectable medication ...

    Comment?

  4. Aralez buys rights to AZ heart drug; encouraged by generic quality issuesRead the original story w/Photo

    Oct 10, 2016 | In-PharmaTechnologist.com

    ... ses at its plant in Wilson, North Carolina, and the following year Ethex - a subsidiary of the now defunct KV Pharmaceutical Company - followed suit. Both versions have been discontinued in the US, according to the FDA's Orange Book.

    Comment?